Model
Edge
BioCryst Pharmaceuticals Inc
0001760020
Filing Type
144
Filing Date
6/13/2024
Updated
6/14/24, 2:08 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities